1.
Sogulasvhili T, Gamkrelidze N, Pavliashvili N, Kvatchadze L, Katsadze M. Colchicine Plus Rosuvastatin/Ezetimibe for Residual Cardiovascular Risk: Mechanistic Rationale, Safety Concerns and Research Priorities. GBMN. 2026;4(3):177-186. doi:10.52340/GBMN.2026.01.01.180